Efficacy study of 0.5% Sodium nitrate compared with Vernonia cinerea (L.) Less. For Reducing nicotine withdrawal symptom of Smoking cessation in IPD at PMNDAT.

Main Article Content

Thayaroch Tipyawong

Abstract

Back ground: Nicotine is the main component in tobacco. Abrupt discontinuation of nicotine induces a withdrawal symptoms that occur peak on approximately the 3rd day and gradually resolved within 3–4 weeks. We used individual counselling combine with quit smoking medications, non-Nicotine replacement therapy: 0.5% Sodium nitrate and Vernonia cinerea (L.) Less (Prep. sprays), to reduce withdrawal symptoms and cigarette cravings. Objective: 1. To evaluate the efficacy of 0.5% sodium nitrate compare with Veronia cinerea (L.) Less. to reduce nicotine withdrawal symptoms and craving smoking cessation. 2. To evaluate the safety of between 0.5% Sodium nitrate and Vernonia cinerea (L.) Less. (Prep. sprays). Methods: The participants of IPD in the PMNDAT were 70 in 2 groups, each adjuncted  with individual counseling for 4 weeks in combination with receiving 0.5% Sodium nitrate and Vernonia cinerea (L.) Less. (Prep. sprays). Follow-up at 1st, 2nd and 4th week. Result: The results showed that 0.5% Sodium nitrate reduced smoking urges factor 1 (Positive Reinforcement) better than Vernonia cinerea (L.) Less. (Prep. sprays). (p-value = 0.047). But smoking urges factor 2 (Relief Negative Symptom) and the two factors, the result was not different (p-value 0.395,p-value = 0.503). In withdrawal symptoms, Vernonia cinerea (L.) Less. (Prep. sprays) no increased appetite and no body weight gain were better than 0.5% Sodium nitrate group (p-value 0.001). Others were not different (p-value> 0.05). However, throughout the study, no serious side effects were observed. And adverse reactions of Vernonia cinerea (L.) Less. (Prep. sprays) (dry throat and coughing) more than 0.5% Sodium nitrate (p-value = 0.032 and 0.006 respectively). Conclusion: Both 0.5% Sodium nitrate and Vernonia cinerea (L.) Less. could reduce craving and nicotine withdrawal symptoms. 0.5% Sodium nitrate can reduce smoking urges in factor 1 better than the Vernonia cinerea (L.) Less.

Article Details

Section
นิพนธ์ต้นฉบับ (Original Article)

References

1) WHO Report on the Global Tobacco Epidemic, 2019 ISBN 978-92-4-151620-4 p 38
2) Benowitz NL. Pharmacology of Nicotine: Addiction, Smoking-Induced Disease, and Therapeutics. Annu Rev Pharmacol Toxicol. 2009 ; 49: 57–71.
3) George O., Koob GF. CHAPTER 1 Overview of Nicotine Withdrawal and Negative Reinforcement (Preclinical). In: F.Scott Hall, Jared W.Young, Andre Der-Avakian. Negative Affective States and Cognitive Impairments in Nicotine Dependence. United Kingdom. Academic Press. 2017. P 2-4.
4) Hughes,J.R., Higgins, S.T., Hatsukami,D. Effects of abstinence from tobacco. In:Kozlowski,L.T.,Annis, H.M.,Cappell,H.D.,et al, eds. Research advances in alcohol and drug problems. New York: Plenum Press, 1990:317-98.
5) Hughes,J.R., et al. Smoking cessation among selfquitters. Health Psychol 199 ;11:331-4.
6) Malcolm S, Rotrosen J. Smoking cessation treatment at substance abuse rehabilitation programs. 2006. Available at http://www.ctndisseminationlibrary.org/pdf/156.pdf, accessed October 27,2015.
7) Benowitz NL. Neurobiology of nicotine addiction: Implication for smoking cessation treatment. Am J med 2008;121:S3-S10.
8) Rigotti N, Munafo MR, Stead LF. Interventions for smoking cessation in hospitalized patients (Review). New York: John Willey & Son; 2008.
9) Lemon SC, Friedmann PD, Stein MD. The impact of smoking cessation on drug abuse treatment outcome. Addict Behav 2003; 28(7): 1323-31
10) Seesin T., Efficacy and Safety of Medications Use in Tobacco Dependence, Efficacy. IJPS Vol.10 No.3 Sep–Dec 2014 : p 256-268
11) A Clinical Practice Guideline for Treating Tobacco Use and Dependence: 2008 Update A U.S. Public Health Service Report The Clinical Practice Guideline Treating Tobacco Use and Dependence 2008 Update Panel, Liaisons, and Staff.
12) Scholz J, Cost-effectiveness analysis of smoking-cessation treatment using electronic medical records in a cardiovascular hospital. Clinical Trials and Regulatory Science in Cardiology 14 (2016) 1–3
13) Cornuz J, Cost-effectiveness of pharmacotherapies for nicotine dependence in primary care settings: a multinational comparison., Tobacco Control 2006;15:152–159. doi: 10.1136/tc.2005.011551
14) Tipyawong T, Ratanasaeng P. Smoking cessation services system in Thailand. Department of Medical Services Journal. 2015; 40: 94-102.
15) Herbal information center, Herbal research institute, Department of Medical Sciences Ministry of Public Health. (2014). Vernonia cinerea, Beside doctor, Comfortable way to stop smoking. Retrieved from http://webdb.dmsc.moph.go.th/ifc_herbal/news_detail.php? cat=G&id=141 [In Thai]
16) Verachai V, Chinpipat A, Nilabun S, Suwanmajo S, Thematheerabunjong R, Pansawat R, Khobthong L, Duangrithi D. The Comparison of Effectiveness Between Vernonia Cenerea (L) Less and bupropion Smoking Cessation. Thai Journal of Addiction. Vol. 2 No. 1 January-June 2014,1-15
17) VC botanical data, therapeutic uses in traditional medicine, chemical constituents and their respective biological activities, as a smoking cessation aid. Journal of Thai Traditional & Alternative Medicine. Division of complementary and Alternative Medicine. 2010; 8(1). [In Thai]
18) Herbal information center, Herbal research institute, Department of Medical Sciences Ministry of Public Health. (2014). Vernonia cinerea, Beside doctor, Comfortable way to stop smoking. Retrieved from http://webdb.dmsc.moph.go.th/ifc_herbal/news_detail.php? cat=G&id=141 [In Thai]
19) Wongwiwatthananukit S, BenjanakaskulP, Songsak T, Suwanamajo S, Verachai V. Efficacy of vernonia cinerea for smoking cessation. Journal of Health Research. 2009; 23(1): 31-6.
20) Pantaewan P, Kengganpanich M, Tanasugarn C, Tansakul S, Termsirikulchai L, Nityasuddhi D. Three intervention levels for improving smoking behavior among Royal Thai Army conscripts. Southeast Asian J Trop Med Public Health. 2012 Jul;43(4):1018-24.
21) Zmeili S, Salhab A, Shubair K, Gharaibeh M, Suliman N, Al-Kayed A, Shubair M, Abu Hijleh N, Abu Jbara M. Clinical evaluation of a new A.S. mouth wash 881010 as an antismoking agent: a placebo-controlled double-blind trial. Int J Clin Pharmacol Ther. 1999 Jan;37(1):41-50.
22) Chaikoolvatana A, Sithibutra C, Chandee S, Chaikoolvatan C. A Comparison of Smoking Cessation Drug Therapies Related Quality of Life between Vernonia cinerea Tea and 0.5% Sodium Nitrate Mouthwash. Nursing journal.Vol. 42 (2015) supplementary; 178-192.
23) Cox LS, Tiffany ST, Christen AG. Evaluation of the brief questionnaire of smoking urges (QSU-brief) in laboratory and clinical settings. Nicotine & Tobacco Research. 2001; 3: 7–16
24) Lancaster T., Stead L. F. Cochrane Tobacco Addiction Group. Silver acetate for smoking cessation. Cochrane Database Syst Rev. 2012. Published online 2012 ;12. doi: 0.1002/14651858.CD000191.pub2
25) Pimsak T, Chaikoolvatana A , Pheunpha P. Quit Smoking Behavior of Current Smokers: A Case Study at Pharsai Clinic, Ubon Ratchathani University Srinagarind Medical Journal. 2015:30; 282-291.